The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line

被引：0
作者：
Mustafa Korkmaz
Melek Karakurt Eryılmaz
Mehmet Zahid Koçak
Muhammed Muhiddin Er
Engin Hendem
Aykut Demirkıran
Murat Araz
Mehmet Artaç
机构：
[1] Necmettin Erbakan University School of Medicine,Department of Medical Oncology
来源：
European Journal of Clinical Pharmacology | 2024年 / 80卷
关键词：
Beta-blocker; Pazopanib; Renal cell carcinoma; Sunitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：941 / 947
页数：6
相关论文
共 150 条
[21]  
Claesson-Welsh L(2021)Impact of concomitant cardiovascular medication on survival of metastatic renal cell carcinoma patients treated with sunitinib or pazopanib in the first line Target Oncol 16 643-undefined
[22]  
Steeghs N(undefined)undefined undefined undefined undefined-undefined
[23]  
Gelderblom H(undefined)undefined undefined undefined undefined-undefined
[24]  
Roodt JO(undefined)undefined undefined undefined undefined-undefined
[25]  
Christensen O(undefined)undefined undefined undefined undefined-undefined
[26]  
Rajagopalan P(undefined)undefined undefined undefined undefined-undefined
[27]  
Hovens MMC(undefined)undefined undefined undefined undefined-undefined
[28]  
Putter H(undefined)undefined undefined undefined undefined-undefined
[29]  
Rabelink TJ(undefined)undefined undefined undefined undefined-undefined
[30]  
De Koning EJ(undefined)undefined undefined undefined undefined-undefined
12345678910